Abbott Laboratories: Buying A Healthcare Giant On Sale [Seeking Alpha]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Seeking Alpha
This is now one of the most severe drawdowns in the company's history, even exceeding in severity the price declines experienced during the 2008-09 global financial crisis. Along with the release of the Q1-26 earnings last week, management has guided for adjusted diluted EPS between $5.38 and $5.58 per share in fiscal 2026. Abbott is currently trading at 16.9x and 15.2x forward earnings for fiscal 2026 and 2027, respectively. Comparable net sales growth is expected between +6.5% and +7.5% in fiscal 2026. I have purchased my first ABT shares today at an average price of $90.81. It remains to be seen whether or not today's low of $90.72 will hold, but in any case, I plan to further increase my position if the share price continues to drift lower. Sundry Photography/iStock Editorial via Getty Images Caught In A Severe Drawdown After initiating Novo Nordisk ( NVO ) with a 'Buy' rating earlier this month, I now turn my attention to another beaten-down healthcare giant, namely
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- A Look At Abbott Laboratories ABT Valuation After New Cancerguard Early Cancer Detection Data [Yahoo! Finance]Yahoo! Finance
- This Boring Dividend King Might Be the Safest Pick to Add to Your Portfolio [Yahoo! Finance]Yahoo! Finance
- ?????????????:2026???2036???? [CNET News]CNET News
- Abbott is the most oversold healthcare stock as Q1 earnings roll on [Seeking Alpha]Seeking Alpha
- Abbott Laboratories (ABT) was downgraded by Daiwa Securities Group Inc. from "outperform" to "neutral". They now have a $92.00 price target on the stock.MarketBeat
ABT
Earnings
- 4/16/26 - Beat
ABT
Sec Filings
- 4/24/26 - Form S-8
- 4/17/26 - Form 8-K
- 4/16/26 - Form 8-K
- ABT's page on the SEC website